Your browser doesn't support javascript.
loading
Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.
Siddiqui, Mahwash; Vora, Amy; Ali, Sadia; Abramowitz, Jessica; Mirfakhraee, Sasan.
Affiliation
  • Siddiqui M; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Vora A; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Ali S; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Abramowitz J; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Mirfakhraee S; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
J Endocr Soc ; 5(1): bvaa171, 2021 Jan 01.
Article in En | MEDLINE | ID: mdl-33294765
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: J Endocr Soc Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: J Endocr Soc Year: 2021 Document type: Article Country of publication: